Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. The FDA recently approved a biosimilar of Stelara from Alvotech and Teva, set to launch early next year. Johnson & Johnson reported mixed sales performance for new multiple myeloma drugs, with Tecvayli sales exceeding expectations and Carvykti underperforming. Roche also released survival data for a new lymphoma drug, potentially giving it an edge over a...

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in the Pharma and Biotech world.## Breakthrough in Cancer TreatmentScientists have discovered a new drug that has shown promising results in treating a rare form of cancer. The drug, which targets specific genetic mutations, has been successful in shrinking tumors in clinical trials. This breakthrough could potentially lead to more effective treatments for other types of cancer as well.## FDA...

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Breakthrough in Cancer TreatmentA new study published in the Journal of Oncology has revealed a groundbreaking discovery in cancer treatment. Researchers have found a novel combination of drugs that have shown significant efficacy in targeting and destroying cancer cells. This new treatment approach has the potential to revolutionize the way we treat cancer...

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Breakthrough in Cancer TreatmentIn a groundbreaking study published in the Journal of Oncology, researchers have discovered a new combination therapy that has shown promising results in treating aggressive forms of cancer. The combination of targeted therapy and immunotherapy has significantly improved survival rates in patients with advanced stage tumors. This...

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Private biotech funding is on the rise, with venture firms investing in cell therapy developments in cancer care. Century has acquired Clade Therapeutics and raised $60 million through a private placement led by Bain Capital to expand its cell therapy technology. In the first quarter of 2024, twenty-six drugmakers raised over $100 million each. The FDA has approved...

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Pfizer is planning to bring an RSV shot to adults aged 18-59, while Boehringer Ingelheim is facing staff layoffs due to biosimilar challenges. Amylyx made a rare move by pulling an ALS drug from the market. On the regulatory front, the FDA has approved CAR-T therapies from J&J and Bristol Myers for earlier use in myeloma patients. Sage's depression drugs are...

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. ## Breakthrough in Cancer ResearchScientists have made a significant breakthrough in cancer research, discovering a new potential treatment that targets specific cancer cells without harming healthy cells. This discovery has the potential to revolutionize cancer treatment and improve outcomes for patients.## Drug Approval for Rare DiseaseThe FDA has approved a new...

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Breakthrough in Cancer TreatmentA recent study published in the Journal of Oncology reported a groundbreaking new treatment for certain types of cancer. The treatment, which involves a combination of immunotherapy and targeted therapy, has shown promising results in clinical trials. Patients who received the treatment experienced a significant reduction in tumor...

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.In the latest edition of Gene Therapy Weekly, Verve pauses its base editing trial due to lab abnormalities in a study participant, prompting a shift in strategy. Ginkgo acquires another startup in search of more cell therapy tools, while Gritstone shares fall after shaky study results for a colorectal cancer vaccine. The newsletter highlights five FDA decisions to...

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.This week's Commercialization Weekly highlights Bristol Myers' success with a Kras drug trial, Astrazeneca's FDA approval for a rare disease drug acquired from Alexion, FDA approval for Akebia's anemia pill after a previous rejection, and Acorda's bankruptcy filing. The FDA is also set to make decisions on expanding the use of two multiple myeloma cell therapies, a...

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Breakthrough in Cancer ResearchTitle: New Drug Shows Promising Results in Clinical TrialsContent: A new drug has shown promising results in clinical trials for the treatment of a specific type of cancer. Researchers have found that the drug has a high success rate in shrinking tumors and improving overall survival rates in patients. This breakthrough could...

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Breakthrough in Cancer TreatmentA recent study published in a leading medical journal has shown promising results in a new cancer treatment. Researchers discovered a novel combination of drugs that effectively target specific cancer cells while minimizing damage to healthy cells. This breakthrough could potentially revolutionize the way we approach cancer...

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Pfizer announces positive results for COVID-19 vaccinePfizer has announced positive results for its COVID-19 vaccine, showing over 90% efficacy in preventing the virus. This is a promising development in the fight against the pandemic.## Moderna reports strong interim data for COVID-19 vaccineModerna has also reported strong interim data for its COVID-19 vaccine,...

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Biotech veteran Art Krieg has postponed his retirement to start a new drug startup called Zola Therapeutics, focusing on cancer immunotherapies without outside investors. Stoke's shares surged on updated results for their drug for Dravet syndrome, a form of genetic epilepsy. Moderna received backing from Blackstone for flu vaccine research and development. Armon...

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Medicare will now cover Novo's obesity drug for patients with a history of heart disease, while the FDA has approved Italfarmaco's Duchenne drug for all patients over six years old. The Supreme Court is currently considering abortion opponents' standing in the Mifepristone case. On the other hand, the FDA has rejected Regeneron's lymphoma drug. Merck has obtained...

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. In the healthcare industry, there are various issues that are being discussed. The government is scrutinizing the VA EHR deployment, as concerns arise about errors in VA and Oracle EHR integration, impacting patient safety. Nonprofit hospitals are facing scrutiny for an imbalance in tax breaks and community care spending, with tax breaks exceeding community care...

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Masimo is planning to spin off its consumer unit two years after acquiring Sound United for its audio brands. In other news, an EU court adviser has sided with Illumina in a dispute that triggered a fine for Grail, Vyaire Medical has recalled resuscitators linked to two deaths, and Medtronic claims a win in a patent dispute with Axonics. The FDA's looming rule on...

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.##FDA Approves New Cancer DrugThe FDA has recently approved a new cancer drug that has shown promising results in clinical trials. This drug is expected to provide a much-needed treatment option for patients with certain types of cancer. ##Biotech Company Announces Breakthrough in Gene Editing TechnologyA biotech company has announced a major breakthrough in gene...

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Orchard has set a record-setting price tag of $4.25 million for its gene therapy Lenmeldy, with hopes of convincing insurers to cover it. The FDA panel has backed broader use of J&J and Bristol Myers cell therapies for myeloma, despite concerns about early death risks. Capstan raised $175 million to advance an autoimmune disease treatment. Following a buyout,...

Good morning from Pharma and Biotech Daily, the podcast that gives you only what's important to hear in Pharma and Biotech world. The FDA panel has approved broader use of J&J and Bristol Myers' cell therapies for myeloma, while Orchard plans to sell the world's priciest gene therapy. Madrigal has won FDA approval for the first drug for Mash, but faces uncertainty regarding sales potential. Additionally, Bio has changed its stance and is backing a bill to limit China's role in US biotech....

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.##Title: Pfizer announces breakthrough in Alzheimer's treatmentPfizer has recently announced a major breakthrough in the treatment of Alzheimer's disease. The pharmaceutical company has developed a new drug that has shown promising results in clinical trials. This drug works by targeting the underlying cause of Alzheimer's, rather than just treating the symptoms....

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in the Pharma and Biotech world. On March 18, 2024, Contineum, a startup formed from a Roche buyout, filed for an IPO. Bluebird, facing financial difficulties, secured $175 million in debt financing. Biotech IPOs are crucial for the industry, and it is important to track their performance. An FDA panel supported broader use of J&J and Bristol Myers' cell therapies for myeloma. Strategies...

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in the Pharma and Biotech world.## Breakthrough in Cancer TreatmentTitle: Breakthrough in Cancer TreatmentContent: Researchers have discovered a new drug that has shown promising results in treating a rare form of cancer. The drug has been found to target specific cancer cells without harming healthy cells, leading to a higher success rate in patients undergoing treatment. This breakthrough...

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Astrazeneca acquired a biotech startup called Amolyt for $800 million, adding a late-stage drug prospect for parathyroidism to its rare disease portfolio. Bio, a lobbying group for the biopharmaceutical industry, changed its stance and now supports a bill to limit China's role in US biotech. German biotech Tubulis secured €128 million in financing to capitalize on the...